International Clinical Trial: Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST)

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07469865) titled 'Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST)' on March 9.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Double (Care Provider, Investigator).

Primary Sponsor: University Hospital, Ghent

Condition: Dry Eye Disease

Intervention: Drug: Preservative-free artificial tears Drug: Autologous serum eyedrops 20%

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: November 30, 2021

Target Sample Size: 46

Countries of Recruitment: Bel...